Target Information
Target General Infomation | |||||
---|---|---|---|---|---|
Target ID |
T98708
|
||||
Former ID |
TTDI01944
|
||||
Target Name |
Parathyroid hormone ligand
|
||||
Gene Name |
PTH
|
||||
Synonyms |
Parathormone; Parathyrin; Parathyroid hormone; PTH
|
||||
Target Type |
Successful
|
||||
Disease | Bone disease [ICD10: M00-M99] | ||||
Osteoporosis [ICD9: 733.0, V07.4; ICD10: M80-M81, Z79.890] | |||||
Osteogenesis imperfecta [ICD9: 756.51; ICD10: Q78.0] | |||||
Parathyroid disease [ICD10: E20-E21] | |||||
Unspecified [ICD code not available] | |||||
Function |
PTH elevates calcium level by dissolving the salts in bone and preventing their renal excretion. Stimulates [1-14C]-2- deoxy-D-glucose (2DG) transport and glycogen synthesis in osteoblastic cells.
|
||||
BioChemical Class |
Parathyroid hormone family
|
||||
UniProt ID | |||||
Sequence |
MIPAKDMAKVMIVMLAICFLTKSDGKSVKKRSVSEIQLMHNLGKHLNSMERVEWLRKKLQ
DVHNFVALGAPLAPRDAGSQRPRKKEDNVLVESHEKSLGEADKADVNVLTKAKSQ |
||||
Drugs and Mode of Action | |||||
Drug(s) | Teriparatide | Drug Info | Approved | Osteogenesis imperfecta | [467716], [536361] |
KUR-111 | Drug Info | Phase 2 | Bone disease | [522008] | |
Ostabolin-C | Drug Info | Phase 2 | Osteoporosis | [549917] | |
ABX-PTH | Drug Info | Terminated | Parathyroid disease | [547899] | |
SUN-E3001 | Drug Info | Terminated | Osteoporosis | [547293] | |
Teriparatide | Drug Info | Investigative | Unspecified | [1572605] | |
Target Expression Profile (TEP) and Drug Resistance Mutation (DRM) | |||||
TEP | EXP Info | ||||
Pathways | |||||
References | |||||
Ref 467716 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4448). | ||||
Ref 522008 | ClinicalTrials.gov (NCT00459641) Safety and Tolerability of I-040302 in Children and Young Adults With Solitary Bone Cysts. U.S. National Institutes of Health. | ||||
Ref 536361 | Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. | ||||
Ref 547293 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014905) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.